ReViral Ltd

ReViral Ltd

ReViral Ltd

ReViral is a UKbased biotechnology company developing firstinclass drugs to treat RSV infections.
Raised
$55M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$55,000,000
Venture capital (Series B) - 2018
New Leaf Venture Partners Perceptive Advisors OrbiMed +3
Team Size
1–10
Employees
PE HUB

VC-backed ReViral taps Musso as CFO

$55,000,000 Venture capital (Series B)
MedCity News , FinSMEs , PE HUB

ReViral closes $55 million Series B funding round for RSV drug